Atossa Therapeutics ATOS
NASDAQ ATOS
$2.14 +0.01 (+0.47%)
At close: Nov 10, 2026 · 4:00 PM EST

Atossa Therapeutics (ATOS) Debt Ratio (2011 - 2015)

Updated

Atossa Therapeutics' (ATOS) Debt Ratio was 0.00 for Q2 2015, down 58.6% from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Debt Ratio (2011 - 2015) Analysis & Trends

Dating back to Q4 2011, Atossa Therapeutics' Debt Ratio record includes 6 quarters.

  • By year, Debt Ratio came in at 0.00 in FY2013 and 0.33 in FY2011.
  • The Q2 2015 figure ranks as the lowest quarterly Debt Ratio since Q4 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Atossa Therapeutics 19.96 Mn -131.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 0.00
Dec 31, 2013 0.00
Sep 30, 2012 0.06
Dec 31, 2011 0.33
API Access

Atossa Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ATOS&period=max&api_key=YOUR_API_KEY